- Home
- MYGN vs OFG Comparison
MYGN vs OFG Comparison
Compare MYGN & OFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYGN
- OFG
- Stock Information
- Founded
- MYGN 1991
- OFG 1964
- Country
- MYGN United States
- OFG United States
- Employees
- MYGN N/A
- OFG N/A
- Industry
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- OFG Major Banks
- Sector
- MYGN Health Care
- OFG Finance
- Exchange
- MYGN Nasdaq
- OFG Nasdaq
- Market Cap
- MYGN 744.7M
- OFG 1.9B
- IPO Year
- MYGN 1995
- OFG N/A
- Fundamental
- Price
- MYGN $5.34
- OFG $44.64
- Analyst Decision
- MYGN Hold
- OFG Buy
- Analyst Count
- MYGN 15
- OFG 3
- Target Price
- MYGN $15.14
- OFG $46.00
- AVG Volume (30 Days)
- MYGN 1.4M
- OFG 273.4K
- Earning Date
- MYGN 08-05-2025
- OFG 07-17-2025
- Dividend Yield
- MYGN N/A
- OFG 2.68%
- EPS Growth
- MYGN N/A
- OFG 6.67
- EPS
- MYGN N/A
- OFG 4.18
- Revenue
- MYGN $831,300,000.00
- OFG $623,009,000.00
- Revenue This Year
- MYGN N/A
- OFG $2.30
- Revenue Next Year
- MYGN $6.68
- OFG $2.61
- P/E Ratio
- MYGN N/A
- OFG $10.68
- Revenue Growth
- MYGN 7.38
- OFG N/A
- 52 Week Low
- MYGN $3.81
- OFG $33.15
- 52 Week High
- MYGN $29.30
- OFG $47.66
- Technical
- Relative Strength Index (RSI)
- MYGN 50.85
- OFG 66.76
- Support Level
- MYGN $4.90
- OFG $44.08
- Resistance Level
- MYGN $5.83
- OFG $45.05
- Average True Range (ATR)
- MYGN 0.28
- OFG 0.84
- MACD
- MYGN 0.04
- OFG 0.15
- Stochastic Oscillator
- MYGN 54.21
- OFG 84.72
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.
About OFG OFG Bancorp
OFG Bancorp is a financial holding company, through its subsidiaries provides banking and financial services. It operates through three segments namely Banking, Wealth Management, and Treasury. It serves to clients such as commercial, consumer, auto, and mortgage lending, checking and savings accounts, financial planning, insurance, financial services, and investment brokerage, and corporate and individual trust and retirement services. The company derives maximum revenue from Banking Segment. It provides services in the region of Puerto Rico.